AstronauTx Ltd, a London, UK-based biotech company, raised£48m ($61m) in Series A financing. The round was led by Novartis Venture Fund, with participation from Brandon Capital, MPM Capital, EQT Life Sciences, Bristol Myers Squibb and founding investor the Dementia Discovery Fund. Following the financing, Jonathan Tobin, UK-based Partner at Brandon Capital will join AstronauTx board of [...]The post AstronauTx Raises £48M in Series A Financing appeared first on FinSMEs.